Search clinical trials for: Ketorolac LS, Bromfenac

Total 554 results

Innovative Medical

Completed

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Vitrectomy

United States
Bucci Laser Vision Institute
Allergan

Completed

A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

Post Operative Anterior Chamber Inflammation (Flare)

United States
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification

Cataracts

United States
Florida Eye Microsurgical Institute
Bausch & Lomb Incorporated

Completed

Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

Dry Eye Disease | Ocular Comfort

United States
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Cataract

United States
University of Copenhagen
The Danish Medical Research Council; Danisco

Completed

The Effect of Probiotics on Low-grade Inflammation, Microbiota and Risk Factors for Metabolic Syndrome in Obese Children

Inflammation | Obesity | Metabolic Syndrome

Denmark
International AIDS Vaccine Initiative
Brigham and Women's Hospital; Fred Hutchinson Cancer Center; Rockefeller University

Active, not recruiting

Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults

HIV-1-infection

United States, Uganda, Kenya, Rwanda, South Africa
Advancing Clinical Therapeutics Globally for HIV...
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa (ACACIA)

HIV-1-infection
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Pausing Antiretroviral Treatment Under Structured Evaluation (PAUSE)

HIV-1-infection

Malawi, South Africa, Botswana
National Institute of Allergy and Infectious Diseases...
Rockefeller University

Withdrawn

Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI

HIV Infections

United States
Imperial College Healthcare NHS Trust
Imperial College London; University of Oxford; Oxford University Hospitals NHS...

Withdrawn

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations (SABRE)

Lymphoma | Leukemia | Immune Thrombocytopenia | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | Myeloma | Thrombotic Thrombocytopenic Purpura (TTP)

United Kingdom
University of Southern California

Completed

Guided Imagery Lifestyle Intervention to Promote Health and Prevent Diabetes in Youth

Obesity | Stress | Insulin Resistance

United States
Rockefeller University

Completed

RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers (RU)

Covid19

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

HIV-1

United States
Hoffmann-La Roche

Completed

A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

Atherosclerosis

United States
Center For Excellence In Eye Care
Allergan

Completed

Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK

Myopia | Hyperopia
Wenzhou Medical University

Recruiting

Comparison of Outcomes With Multifocal Intraocular Lenses (COMIL)

Cataract

China
Università degli Studi di Brescia

Completed

NSAIDs and PGE2 Levels in Vitrectomy Patients

Vitreous Inflammation
University of Campinas, Brazil

Completed

Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery

Cystoid Macular Edema Following Cataract Surgery, Bilateral

Brazil
Imperial College London
Bill and Melinda Gates Foundation; University of Oxford; Rockefeller University

Recruiting

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs). (RIO)

HIV/AIDS and Infections

Denmark, United Kingdom
Federal University of Minas Gerais
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...

Completed

Release of Organic Components of a GIOMER in Non-carious Cervical Lesion Restorations

Non-carious Cervical Lesions

Brazil
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants (HVTN143)

HIV Infections

South Africa
Tufts University
Shofu Inc.

Completed

Clinical Evaluation of a New Giomer Restorative System in Class V Restorations

Non-carious Cervical Lesions

United States
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification

Cataracts
Rockefeller University

Completed

3BNC117-LS First-in-Human Phase 1 Study

Human Immunodeficiency Virus

United States
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Department of Health and Human Services

Completed

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States, Zimbabwe, Kenya, South Africa
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Classical Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)

Italy
Haag-Streit AG
Aravind Eye Hospitals, India

Not yet recruiting

Clinical Study - ES 900 - 2020-1

Cataract

India
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection

HIV-1 Infection

United States
LS BioPath

Completed

In Vitro Detection of Tissue Abnormality

Breast Cancer Female

United States
Rigshospitalet, Denmark
Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital and other collaborators

Recruiting

Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment - Validation Study (FAST2)

Surfactant Deficiency Syndrome Neonatal | Respiratory Distress Syndrome in Premature Infant

Denmark
Nocimed, LLC

Not yet recruiting

NOCISCAN-Lumbar Spine (LS) Clinical Evaluation Study

Lumbar Disc Disease

United States
Zagazig University

Completed

Different Maneuvers for Reducing Post-laparoscopic Pain

Gynecologic Disease

Egypt
University of South Alabama

Terminated

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity (ROP)

Retinopathy of Prematurity | Blindness | Retinal Detachment

United States
Rockefeller University

Completed

First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS

Human Immunodeficiency Virus

United States
Vanderbilt University

Completed

Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study (INCITE)

Inflammation

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; HIV Prevention Trials Network

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States
Bausch & Lomb Incorporated

Completed

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Dry Eye Syndrome

United States
Izmir Democracy University

Not yet recruiting

The Effects of Different Surgical Stabilization Methods in Recurrent Anterior Shoulder Instability (SSM-SI)

Surgery | Anterior Shoulder Instability
Rigshospitalet, Denmark
Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital and other collaborators

Not yet recruiting

Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment (FAST2)

Respiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia | Surfactant Deficiency Syndrome Neonatal

Denmark
Sun Yat-sen University
Second Military Medical University

Not yet recruiting

Laparoscopic Surgery VS RFA for Recurrent HCC

Hepatocellular Carcinoma
Bp Consulting, Inc

Completed

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

Acute Pseudophakic Cystoid Macular Edema

United States
Allergan

Completed

Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

Inflammation

United States
Seattle Children's Hospital

Completed

Study of an Exercise Program (STEP) for Youth With Concussion (STEP)

Persistent Concussion Symptoms

United States
Medtronic Endovascular

Completed

Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)

Peripheral Arterial Disease
Emory University

Completed

Topical 0.4% Ketorolac and Vitreoretinal Surgery

Surgery

United States
Oman Medical Speciality Board

Completed

Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. (Ink-Arc)

Acute Renal Colic

Oman
Melissa Toyos
Bausch & Lomb Incorporated

Completed

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (QD)

Inflammation | Cataract | Retinal Edema

United States
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Repeatability in Measurements of Two ssOCT and One OLCR Biometer

Cataract Senile

Austria
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

Human Immunodeficiency Virus

United States

Search clinical trials for: Ketorolac LS, Bromfenac

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations